Improved treatment and survival for lung cancer patients in south-east Scotland

Journal of Thoracic Oncology

Volumn 3, Issue 5, 2008, Pages 491-498

  Erridge, Sara C ^a,b   Murray, Brian ^c   Price, Allan ^a,b   Ironside, Janet ^a   Little, Felicity ^a   Mackean, Melanie ^a,b   Walker, William ^b,d   Brewster, David H ^b,c   Black, Roger ^c   Fergusson, Ron J ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

^c HEALTHCARE IMPROVEMENT SCOTLAND   (United Kingdom)

^d ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

Lung cancer; Population based; Survival; Treatment

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DATA BASE; DISEASE ASSOCIATION; FEMALE; HEALTH HAZARD; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 43049107561     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0b013e31816fca46     Document Type: Article

References (45)

1. F Berrino R De Angelis M Sant Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995–99: results of the EUROCARE-4 study Lancet Oncol 8 2007 773 783
2. MP Coleman B Rachet LM Woods Trends and socioeconomic inequalities in cancer survival in England and Wales up to 2001 B J Cancer 90 2004 1367 1373
3. M Talback M Stenbeck M Rosen Cancer survival in Sweden 1960–1998–developments across four decades Acta Oncologica 42 2003 637 659
4. SC Erridge CS Thomson J Davidson Factors influencing the use of thoracic radiotherapy in lung cancer-an analysis of the 1995 Scottish lung cancer audit Clin Oncol (R Coll Radiol) 14 2002 219 227
5. RJ Fergusson CS Thomson D Brewster Lung cancer: the importance of seeing a respiratory physician Eur Respir J 21 2003 606 610
6. A Gregor CS Thomson DH Brewster Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study Thorax 56 2001 212 217
7. Information-Statistics-Division Available at: www.isdscotland.org Accessed March 31, 2008.
8. CA Butler GP Currie WJ Anderson Do differences in data reporting contribute to variation in lung cancer survival? Journal of the National Cancer Institute 97 2005 1385
9. PW Dickman E Coviello M Hills Estimating and modeling relative survival http://www.pauldickman.com/survival/strs.pdf
10. F Ederer L Axtell S Cutler The Relative Survival Rate: A Statistical Methodology National Cancer Institute Monograph 6 1961 101 121
11. M Coleman G Gatta A Verdecchia EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century Ann Oncol 14 suppl 5 2003 128 149
12. JJ Laskin SC Erridge AJ Coldman Population-based outcomes for small cell lung cancer: impact of standard management policies in British Columbia [see comment] Lung Cancer 43 2004 7 16
13. N Bossard M Velten L Remontet Survival of cancer patients in France: A population-based study from The Association of the French Cancer Registries (FRANCIM) Eur J Cancer 43 2006 149 160
14. JB Fu TY Kau RK Severson Lung cancer in women: analysis of the SEER database Chest 127 2005 768 777
15. BG Campling WT Hwang J Zhang A population-based study of lung carcinoma in Pennsylvania: comparison of Veterans Administration and civilian populations Cancer 104 2005 833 840
16. SJ Demeter C Chmielowiec W Logus The descriptive epidemiology of primary lung cancer in an Alberta cohort with a multivariate analysis of survival to two years Canadian Respiratory J 10 2003 435 441
17. SM Gadgeel RK Severson Y Kau Impact of race in lung cancer: analysis of temporal trends from a SEER database Chest 120 2001 55 63
18. K McDavid TC Tucker A Sloggett Cancer survival in Kentucky and health insurance coverage Arch Intern Med 163 2003 2135 2144
19. GE Richardson VJ Thursfield GG Giles Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group. [see comment] Med J Australia 172 2000 321 324
20. M Sant T Aareleid F Berrino EUROCARE-3: survival of cancer patients diagnosed 1990–94–results and commentary Ann Oncol 14 suppl 5 2003 v61 v118
21. SK Vinod AC Hui N Esmaili Comparison of patterns of care in lung cancer in three area health services in New South Wales, Australia Intern Med J 34 2004 677 683
22. S Erridge H Moller A Price International comparisons of survival from lung cancer: pitfalls and warnings Nat Clin Pract Oncol 2007 in press.
23. EF Harkness DH Brewster KM Kerr Changing trends in incidence of lung cancer by histologic type in Scotland Int J Cancer 102 2002 179 183
24. R Berrisford A Brunelli G Rocco The European Thoracic Surgery Database project: modelling the risk of in-hospital death following lung resection Eur J Cardiothorac Surg 28 2005 306 311
25. J Freixinet G Julia-Serda P Rodriguez Hospital volume: operative morbidity, mortality and survival in thoracotomy for lung cancer. A Spanish multicenter study of 2994 cases Eur J Cardiothorac Surg 21 2006 20 25
26. T Strand H Rostad B Moller Survival after resection for primary lung cancer. A population-based material of 3211 resected patients Thorax 2006
27. SM Mahmud M Reilly H Comber Patterns of initial management of lung cancer in the Republic of Ireland: a population-based observational study Lung Cancer 41 2003 57 64
28. R Makitaro P Paakko E Huhti Prospective population-based study on the survival of patients with lung cancer Eur Respir J 19 2002 1087 1092
29. RH Jack MC Gulliford J Ferguson Geographical inequalities in lung cancer management and survival in South East England: evidence of variation in access to oncology services? [erratum appears in Br J Cancer 2004 Nov 15;91(10):1852.] Br J Cancer 88 2003 1025 1031
30. H Tunstall-Pedoe K Kuulasmaa M Mahonen Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from WHO MONICA project Lancet 353 1999 1547 1557
31. ML Cartman AC Hatfield MF Muers Lung cancer: district active treatment rates affect survival J Epidemiol Community Health 56 2002 424 429
32. JM de Rijke LJ Schouten GP ten Velde Influence of age, comorbidity and performance status on the choice of treatment for patients with NSCLC; results of a population-based study Lung Cancer 46 2004 233 245
33. AJ Vulto MW Louwman P Rodrigus Referral rates and trends in radiotherapy as part of primary treatment in cancer in South Netherlands, 1988–2002 Radiother Oncol 78 2006 131 137
34. L Barbera J Zhang-Salomons J Huang Defining the need for radiotherapy for lung cancer in the general population: a benchmarking approach Medical Care 41 2003 1074 1085
35. S Tyldesley C Boyd K Schulze Estimating the need for radiotherapy for lung cancer: an evidence-based, epidemiologic approach Int J Radiat Oncol Biol Phys 49 2001 973 985
36. G Delaney M Barton S Jacob A model for decision making for the use of radiotherapy in lung cancer Lancet Oncol 4 2003 120 128
37. J Hayman P Abrahamse I Lakhani Use of palliative radiotherapy among patients with metastatic non-small-cell lung cancer Int J Radiat Oncol Biol Phys 69 2007 1001 1007
38. MH Cullen LJ Billingham CM Woodroffe Mitomycin, ifosfamide, and cisplatin in un-resectable non-small-cell lung cancer: effects on survival and quality of life J Clin Oncol 17 1999 3188 3194
39. Anonymous Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group BMJ 311 1995 899 909
40. N Patel R Adatia A Mellemgaard Variation in the use of chemotherapy in lung cancer Br J Cancer 96 2007 86 90
41. CC Earle PJ Neumann RD Gelber Impact of referral patterns on the use of chemotherapy for lung cancer J Clin Oncol 20 2002 1786 1792
42. M Lebitasy G Hedelin A Purohit Progress in the management and outcome of small-cell lung cancer in a French region from 1981 to 1994 Br J Cancer 85 2001 808 815
43. AT Turrisi 3rd K Kim R Blum Twice-daily compared with once-daily thoracic radiotherapy in limited small-cell lung cancer treated concurrently with cisplatin and etoposide [see comment] N Engl J Med 340 1999 265 271
44. J Foegle G Hedelin MP Lebitasy Non-small-cell lung cancer in a French department, (1982–1997): management and outcome B J Cancer 92 2005 459 466
45. D Brooks A Klint P Dickman Temporal trends in NSCLC survival in Sweden Br J Cancer 96 2007 519 522